GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (NAS:SRDX) » Definitions » Cyclically Adjusted PB Ratio

Surmodics (Surmodics) Cyclically Adjusted PB Ratio : 2.62 (As of Apr. 29, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Surmodics Cyclically Adjusted PB Ratio?

As of today (2024-04-29), Surmodics's current share price is $25.85. Surmodics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $9.86. Surmodics's Cyclically Adjusted PB Ratio for today is 2.62.

The historical rank and industry rank for Surmodics's Cyclically Adjusted PB Ratio or its related term are showing as below:

SRDX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.8   Med: 3.35   Max: 9.11
Current: 2.65

During the past years, Surmodics's highest Cyclically Adjusted PB Ratio was 9.11. The lowest was 1.80. And the median was 3.35.

SRDX's Cyclically Adjusted PB Ratio is ranked worse than
58.99% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs SRDX: 2.65

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Surmodics's adjusted book value per share data for the three months ended in Dec. 2023 was $8.581. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $9.86 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Surmodics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Surmodics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics Cyclically Adjusted PB Ratio Chart

Surmodics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.27 4.54 6.17 3.15 3.24

Surmodics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.55 2.34 3.19 3.24 3.69

Competitive Comparison of Surmodics's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Surmodics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surmodics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Surmodics's Cyclically Adjusted PB Ratio falls into.



Surmodics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Surmodics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=25.85/9.86
=2.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surmodics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Surmodics's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=8.581/129.4194*129.4194
=8.581

Current CPI (Dec. 2023) = 129.4194.

Surmodics Quarterly Data

Book Value per Share CPI Adj_Book
201403 6.672 99.695 8.661
201406 6.964 100.560 8.963
201409 7.258 100.428 9.353
201412 6.311 99.070 8.244
201503 6.548 99.621 8.507
201506 6.890 100.684 8.856
201509 7.097 100.392 9.149
201512 7.331 99.792 9.507
201603 7.595 100.470 9.783
201606 7.883 101.688 10.033
201609 8.088 101.861 10.276
201612 8.078 101.863 10.263
201703 8.241 102.862 10.369
201706 8.341 103.349 10.445
201709 8.519 104.136 10.587
201712 8.378 104.011 10.425
201803 8.557 105.290 10.518
201806 8.147 106.317 9.917
201809 8.107 106.507 9.851
201812 8.428 105.998 10.290
201903 8.549 107.251 10.316
201906 8.794 108.070 10.531
201909 9.073 108.329 10.839
201912 9.073 108.420 10.830
202003 9.182 108.902 10.912
202006 9.570 108.767 11.387
202009 9.586 109.815 11.297
202012 9.710 109.897 11.435
202103 10.245 111.754 11.864
202106 10.152 114.631 11.462
202109 10.079 115.734 11.271
202112 9.780 117.630 10.760
202203 9.526 121.301 10.164
202206 8.937 125.017 9.252
202209 7.726 125.227 7.985
202212 7.593 125.222 7.848
202303 7.256 127.348 7.374
202306 7.953 128.729 7.996
202309 8.471 129.860 8.442
202312 8.581 129.419 8.581

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Surmodics  (NAS:SRDX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Surmodics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Surmodics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Surmodics (Surmodics) Business Description

Traded in Other Exchanges
Address
9924 West 74th Street, Eden Prairie, MN, USA, 55344
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
Executives
Jose H Bedoya director
David Dantzker other: See Explanation of Responses 80 CUTTERMILL ROAD STE 311, GREAT NECK NY 11021
Kalich Ronald B Sr director
Gary R Maharaj director, officer: President & CEO 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Joseph J. Stich officer: VP, Corp Dev & Strat Planning 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Charles W Olson officer: General Manager
John D. Manders officer: Corporate Controller 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Gordon S. Weber officer: Sr. VP of Legal, GC and Sec. 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Nusrath Sultana officer: VP, Clinical Affairs 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Lisa Wipperman Heine director 1244 76TH STREET WEST, INVER GROVE HEIGHTS MN 55077
Teri Woodwick Sides officer: Senior VP and CMO 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Gregg S Sutton officer: VP of Research and Development 6464 SYCAMORE COURT NORTH, MINNEAPOLIS MN 55369
Susan E Knight director 9154 BRECKENRIDGE LANE, EDEN PRAIRIE MN 55437
Bryan K Phillips officer: Dep. Gen. Counsel & Corp. Sec. 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Timothy J. Arens officer: General Manager - IVD 9924 WEST 74TH STREET, EDEN PRAIRIE X1 55344